title: Association between increased levels of IL-2 and IL-15 and outcome in patients with early acute respiratory distress syndrome.
abstract: BACKGROUND
  Acute respiratory distress syndrome remains a serious, often fatal, condition, despite progress in modern critical care treatment. Cytokines play an important role in the pathogenesis of the syndrome, although their role in the evolution and outcome has not been clearly elucidated. We explored whether the measurement of serum and bronchoalveolar lavage IL-2 and IL-15 at the time of hospital admission can predict the outcome of this syndrome.
  
  
  METHODS
  Serum and bronchoalveolar lavage levels of IL-2 and IL-15 were measured in eight patients with ARDS (group A) and 26 patients on high risk for ARDS development who never developed ARDS (group B) from samples obtained at the time of admission.
  
  
  RESULTS
  Serum IL-2 (P > 0.05) and IL-15 (P < 0.05) levels were higher in group A than in group B. Serum levels of both cytokines were higher in patients who did not survive in both of the groups A and B compared to those who survived (P < 0.05, and P < 0.0001, respectively). The only significant change in BALF was the higher level of IL-15 in surviving group A patients (P < 0.05) when compared with the non survivors of the same group. For a serum cut-off level of 173 pg mL(-1) for IL-2 and 250 pg mL(-1) for IL-15, they exhibited a very high positive predictive value (PPV), negative predictive value (NPV), sensitivity and specificity for survival (100% in all). A positive correlation was found between serum levels of both cytokines and APACHE II score (IL-2, r = 0.61, and IL-15, r = 0.62, respectively, and P < 0.0001 for both).
  
  
  CONCLUSIONS
  Determination of serum IL-2 and IL-15 levels may be a valuable and simple aid to improve identification of patients with ARDS or at risk for ARDS who are at high risk of subsequent mortality.
authors.affiliation: Intensive Care Unit, General Hospital of Rethymnon, Crete, Greece.
authors.forename: P
authors.initials: P
authors.lastname: Agouridakis
authors.forename: D
authors.initials: D
authors.lastname: Kyriakou
authors.forename: M G
authors.initials: MG
authors.lastname: Alexandrakis
authors.forename: K
authors.initials: K
authors.lastname: Perisinakis
authors.forename: N
authors.initials: N
authors.lastname: Karkavitsas
authors.forename: D
authors.initials: D
authors.lastname: Bouros
mesh_terms: D018806:APACHE; D015415:Biomarkers / Q000032:analysis / Q000097:blood; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry; D016022:Case-Control Studies; D016207:Cytokines / Q000032:analysis* / Q000097:blood; D006801:Humans; D019409:Interleukin-15 / Q000032:analysis / Q000097:blood; D007376:Interleukin-2 / Q000032:analysis / Q000097:blood; D011237:Predictive Value of Tests; D011446:Prospective Studies; D012372:ROC Curve; D012128:Respiratory Distress Syndrome / Q000276:immunology* / Q000401:mortality; D012680:Sensitivity and Specificity; D018709:Statistics, Nonparametric
chemical_list: D015415:Biomarkers; D016207:Cytokines; D019409:Interleukin-15; D007376:Interleukin-2